COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > New Press Release - COSCIENS Biopharma Announces Change to Board of Directors

<< Previous

Bullboard Posts

Next >>

Comment by Hopeforthebeston Oct 08, 2024 11:39am

157 Views

Post# 36257916

RE:New Press Release - COSCIENS Biopharma Announces Change to Board of Directors

With gagnon leaving and not having someone to tell her what to do and say, it was inevitable that sweet Carolyn would jump the sinking ship.
Was not a bad gig for the last 12 years, only do as gagnon says (just ask proph) and collect well over $1,000,000US during that time period.

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch